Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EMC Microcollections is a German biotechnology company specializing in combinatorial chemistry and the synthesis of high-quality chemical libraries for drug discovery. Founded in 1996 as a spin-off from the University of Tübingen, the company provides a wide range of products including peptide libraries, lipopeptides, and small molecule collections. They are particularly well-known for their expertise in Toll-like receptor (TLR) ligands, such as Pam3Cys derivatives used extensively in immunology research and vaccine development. In addition to their extensive catalog of research chemicals, EMC offers custom synthesis and contract research services to pharmaceutical, biotech, and academic partners worldwide. Their platform enables the rapid generation of diverse compound sets for lead identification and optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMC Microcollections.